Dr. Reddy's Laboratories Ltd.NSE: DRREDDY

Press Release Oct 02 2024

· Issued by Dr. Reddy's Laboratories Ltd.

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-oct-02-2024

Watch Dr. Reddy's Laboratories' latest callDr. Reddy's Laboratories (NSE:DRREDDY) Q1 2027 Earnings Call · Replay · Jul 22Read the transcript of Dr. Reddy's Laboratories (NSE:DRREDDY) Q1 2027 Earnings Call

Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 02, 2024, titled "Dr. Reddy s signs voluntary licensing agreement with Gilead Sciences to manufacture and commercialise Lenacapavir in India and other countries .

View Attachment

6ix hasn’t read this filing yet.

Dr. Reddy's Laboratories Ltd. on 6ix

Earlier from Dr. Reddy's Laboratories

Later from Dr. Reddy's Laboratories

All Dr. Reddy's Laboratories news releases